Novartis new two-year data with Certican(R) shows positive outcomes at 24 ... Reuters Calcineurin inhibitors like tacrolimus are part of the standard immunosuppression regimen after a liver transplant but may contribute to a decline in renal function over time [2],[3]; Certican was ... The trial evaluated the introduction of Certican ... Novartis' Certican succeeds in liver transplant trial Certican derives Successful Result |
